Charles River Laboratories International, Inc. trades under ticker CRL on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US1598641074, CUSIP 159864107. Also searched as Charles River Laboratories International.
Related researchCRL stock priceCRL share priceCRL dividend historyCRL dividend yieldCharles River Laboratories International dividend historyCharles River Laboratories International dividend yield159864107Charles River Laboratories International stockCharles River Laboratories International share price
About the Company
Charles River Laboratories International, Inc. is a global drug development services company that supports pharmaceutical, biotechnology, and medical device organizations across the research and preclinical stages. Charles River Laboratories provides research models, discovery services, non-clinical safety assessment, and manufacturing-related testing solutions that help clients evaluate new therapies and products before clinical use. Its business spans three main segments: Research Models and Services, Discovery and Safety Assessment, and Manufacturing Solutions. The company also offers specialized support for biologics, microbial testing, endotoxin testing, and cell-based research, serving customers in life sciences, academia, and government research. Headquartered in Wilmington, Massachusetts, Charles River Laboratories plays a key role in the outsourced research and development ecosystem by supplying the tools, services, and scientific expertise used to advance drug discovery and product safety worldwide.